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Objective: To examine the association between Type D personality and illness perceptions among colorectal
cancer survivors 1–10 years post-diagnosis.
Methods: Data from two population-based surveys on colorectal cancer survivors was used. Patients diag-
nosed between 1998 and 2009, as registered in the Eindhoven Cancer Registry, received a questionnaire on
Type D personality (DS14) and illness perceptions (B-IPQ); 81% (n=3977) responded.
Results: 750 (19%) patients had a Type D personality. They believe their illness has signiﬁcantly more serious
consequences, will last signiﬁcantly longer, and experience signiﬁcantly more symptoms that they attribute
to their illness. Also, they are more concerned about their illness, and their disease more often inﬂuences
them emotionally. Differences regarding ‘consequences’, ‘concern’ and ‘emotional response’ were also clini-
cally relevant. The majority of patients stated that the cause of their disease was unknown (23.3%), heredi-
tary (20.3%), lifestyle (15.1%), psychological distress (11.9%) or other (11.6%). Signiﬁcant differences in
perceptions on cause of disease between Type Ds and non-Type Ds were found for psychological distress
(16.2 vs. 10.9%; pb0.01), randomness (1.7 vs. 5.3%; pb0.01) and unknown (18.8 vs. 24.4%; pb0.01). Multivar-
iate analyses showed that Type D was negatively associated with ‘coherence’ and positively with ‘conse-
quences’, ‘timeline’, ‘identity’, ‘concern’, and ‘emotional representation’.
Conclusions: These results elucidate the associations between personality and illness perceptions, demon-
strating their close interrelatedness. Our study may be helpful in further developing theoretical models re-
garding giving meaning to illness and the illness perceptions that the illness elicits. Future studies should
investigate whether interventions can positively impact illness perceptions of Type D cancer patients.© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Type D (distressed) personality has become an important research
topic in the ﬁeld of medical psychology in recent years. It has been de-
scribed as the tendency to experience a high joint occurrence of neg-
ative affectivity and social inhibition [1]. People who score high on
negative affectivity have the tendency to experience negative emo-
tions, while people who score high on social inhibition have theNA), Negative affectivity; (SI),
ith the style of the journal, and
ipt is not being considered for
ript have not been previously
ychology in Somatic Diseases
urg, The Netherlands.
ls).
vier OA license.tendency not to express these emotions, because of fear of rejection
or disapproval by others. Those with high levels on both personality
traits are classiﬁed as having a Type D personality [1].
Systematic reviews among various patient groups [2,3] and
healthy individuals [4] have shown that Type D personality is a stable
[1,5] and powerful predictor of impaired quality of life and mental
health status, above and beyond clinical characteristics. Also, studies
have shown that individuals with a Type D personality reported
higher rates of medically documented comorbidity [6,7], more somat-
ic complaints [8–11], and report to feel more bothered by their illness
[7,12,13] compared to those without this personality type. Findings
on health care utilization among those with a Type D personality
are mixed. While some studies have shown that patients with a
Type D personality are less likely to seek appropriate medical care
[9,12,14,15], a recent publication among cancer survivors concluded
the opposite [7].
There is still a signiﬁcant gap in our understanding of the determi-
nants of these poor health outcomes among patients with a Type D per-
sonality. Perhaps the way people perceive their illness can shed some
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to determine their behavioral and emotional self-regulation following a
health threat [16]. A recent study among post myocardial infarction pa-
tients showed that those with a Type D personality possess a distinct
proﬁle of health beliefs compared to those without this personality
type [17]. They believed that their illness had more serious conse-
quences,will last signiﬁcantly longer, will be signiﬁcantly less controlla-
ble by them or through treatment, and they experienced signiﬁcantly
more symptoms that they attributed to their illness. Also, they were
more concerned about their illness, experiencedmore emotions as a re-
sult of it, and found their illness to be less comprehensible [17].
Patients respond to their symptoms and signs of illness by
forming cognitive and emotional representations of the illness that
lead to coping responses [18]. However, the study amongmyocardial
infarction patients showed that personality might inﬂuence the way
people perceive their illness [17]. Besides that study, the inﬂuence of
Type D personality on illness perceptions has not been investigated
before. Because cancer patients with a Type D personality experience
a lower quality of life and mental health status [19], report higher
rates of comorbid conditions [7], and report to feel more bothered
these conditions [7], assessing illness perceptions among cancer pa-
tients with and without a Type D personality seems warranted.
Therefore, the goal of this study was to examine whether colorectal
cancer survivors between 1 and 10 years after diagnosis with a
Type D personality have different illness perceptions compared to
non-Type Ds.Methods
Setting and participants
Data collection was done within PROFILES (Patient Reported Out-
comes Following Initial treatment and Long term Evaluation of Survi-
vorship). PROFILES is a registry for the study of the physical and
psychosocial impact of cancer and its treatment from a dynamic, grow-
ing population-based cohort of both short- and long-term cancer survi-
vors [20]. PROFILES contains a large web-based component and is
linked directly to clinical data from the Eindhoven Cancer Registry
(ECR), which compiles data of all individuals newly diagnosedwith can-
cer in the southern part of the Netherlands, an area with 10 hospitals
serving 2.3 million inhabitants [21]. Data from the PROFILES registry
will be available for non-commercial scientiﬁc research, subject to
study question, privacy and conﬁdentiality restrictions, and registration
(www.proﬁlesregistry.nl).
For this study, data from two large population-based surveys on
survivors of colorectal cancer was used [22,23]. These surveys were
set up in January 2009 and December 2010 with the goal to evaluate
various patient-reported outcomes (e.g. late effects, physical and
mental health status) among colorectal cancer survivors. For the
2009 survey, all individuals diagnosed with colorectal cancer from
1998 to 2007 as registered in the ECR were eligible for participation.
However due to the large number of colorectal cancer survivors
(n=5399), a weighted random selection of 2219 patients based on
tumor, gender, and year of diagnosis was made [22,23]. Patients
with fewer years since diagnosis were oversampled. For the 2010 sur-
vey, all individuals diagnosed with colorectal cancer from 2000 to
2009 as registered in the ECR were eligible for participation (except
those already included in the 2009 survey). In both surveys, patients
who had cognitive impairment, those who died prior to start of study
(according to the ECR, hospital records, and the Central Bureau for
Genealogy which collects information on all deceased Dutch citizens
via the civil municipal registries) or those with unveriﬁable ad-
dresses, were excluded. Both studies were approved by the Medical
Ethics Committee of the Maxima Medical Centre in the Netherlands
and carried out to conform to the Helsinki Declaration.Data collection
Details of the PROFILES data collection method have been previ-
ously described [20]. In summary, survivors were informed of the
study via a letter from their (ex-)attending specialist. The 2009 let-
ter explained that by completing and returning the enclosed
paper-and-pencil questionnaire, patients consented to participate
in the study and agreed to the linkage of the questionnaire data
with their disease history in the ECR. The 2010 letter included a
link to a secure website, a login name, and a password, so that in-
terested patients could provide informed consent and complete
questionnaires online. If the patient did not have access to the in-
ternet, or preferred written rather than digital communication,
(s)he could return our postcard by mail after which (s)he received
our paper-and-pencil version of the informed consent form and
questionnaire. In both studies, patients were reassured that
non-participation had no consequences on their follow-up care or
treatment. Non-respondents were sent a reminder letter and
paper-and-pencil questionnaire within 2 months.
Demographic and clinical characteristics
Survivors' sociodemographic and clinical information was available
from the ECR which routinely collects data like date of diagnosis,
tumor grade [24], clinical stage [24], and primary treatment. Comor-
bidity at the time of the study was assessed with the adapted
Self-administered Comorbidity Questionnaire [25]. Socioeconomic sta-
tuswas determined by an indicator developed by Statistics Netherlands
[26]. Questions on marital status, educational level, and employment
status were added to the questionnaire.
Type D personality
Type D personality was measured with the Dutch 14-item Type D
Personality Scale (DS14) [1]. The DS14 is self-administered and takes
only a few minutes to complete. The 14 items of this scale are an-
swered on a 5-point response scale ranging from 0 (false) to 4
(true). Seven of these items refer to “Negative Affectivity” (NA) or
the tendency to experience negative emotions in general. The
remaining 7 items refer to the patient's level of “Social Inhibition”
(SI) or the tendency to inhibit the expression of emotions in social in-
teraction. Patients were categorized as having a Type D personality
using a standardized cut-off score of ≥10 on both the negative affec-
tivity and social inhibition subscales, following the protocol as previ-
ously established [1]. The DS14 is a valid and reliable scale with
Cronbach's α of 0.88/0.86 and a test–retest reliability over a
3-month period of r=0.72/0.82 for the two subscales, respectively
[1].
Illness perceptions
Illness perceptions were assessed using the Dutch version of the
Brief Illness Perception Questionnaire (B-IPQ), an eight-item instru-
ment used to assess cognitive and emotional representations of the
illness [27]. The B-IPQ uses a single-item scale approach to assess per-
ceptions on a continuous linear 0–10 point scale. Five of the items as-
sess cognitive illness representations: 1. How much does your illness
affect your life (consequences)? 2. How long do you think your illness
will continue (timeline)? 3. How much control do you feel you have
over your illness (personal control)? 4. How much do you think
your treatment can help your illness (treatment control)? and 5.
Howmuch do you experience symptoms from your illness (identity)?
Two items assess emotional representations: 6. How concerned are
you about your illness (concern)? and 7. How much does your illness
affect you emotionally (emotional representation)? One item as-
sesses illness comprehensibility: 8. How well do you understand
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whereby survivors are asked to list the 3 most important causes for
their illness. Responses can be grouped into categories determined
by the particular illness studied.
Depression
Some symptoms of cancer may overlap with the somatic com-
plaints of depression. We therefore used the Dutch version of the
Hospital Anxiety and Depression Scale (HADS) since this question-
naire lacks physical indicators of psychological distress such as fa-
tigue or weight loss, which could give false positive results if they
were in fact due to (cancer or its treatment [28]). The HADS is a
self-report questionnaire comprising 14 items on a four-point
Likert-scale; 7 for depression and 7 for anxiety. The depression
subscale mainly covers anhedonia and loss of interest, which are con-
sidered core depressive symptoms. We used a score of 8 as a cut-off
value [28,29].
Statistical analyses
Routinely collected data from the ECR on patient and tumor
characteristics enabled us to compare the group of respondents,
non-respondents and patients with unveriﬁable addresses, using
t-tests for continuous variables and chi-square analyses for categor-
ical variables. We used non-parametric equivalents, where appropri-
ate. Differences in sociodemographic and clinical characteristics2009 Data collection
5399 survivors £85 years at time  
of study and registered with 
rectal cancer between 1998 and 
2007 and living in the region of 
theECR1
2219 survivors randomly 
selected using weights on tumor 
site, incident year and sex  
Specialists from 10 hospital 
locations received an invitation 
letter to participate in this study 
Status of the remaining 1940 
survivors checked against ECR1
and hospital records 
1 hospital declined participation: 
279 
A questionnaire was sent to the 
remaining 1682 survivors 
1371 (82%) survivors returned a 
completed questionnaire  
Double selections: 39 
Unverifiable address: 150 
Patient demented /terminally ill: 6 
Tumor not staged: 56 
Initial diagnosis outside ECR: 7 
311 (18%) patients did not 
complete the questionnaire of 
whom 70 actively refused or were  
too ill 
Respondents from the 2009 
data collections: 399
14 respondents in 2010 data 
also completed a 2009 ques
Their 2010 responses were e
Total respondents included i
3977  
Fig. 1. Flowchart shows thebetween respondents with respect to Type D personality were ana-
lyzed in a similar way.
The B-IPQ mean scores, stratiﬁed by Type D personality, were
compared with analysis of covariance (ANCOVA). Confounding
background variables included for adjustment in these analyses
were determined a priori [30] and chosen to be socioeconomic
status, self-reported comorbidity, educational level, gender and
depressive symptoms. Clinically meaningful differences were deter-
mined with Norman's ‘rule of thumb’, whereby a difference of≈0.5
SD indicates a threshold of discriminant change in scores of a chron-
ic illness [31]. In addition, the B-IPQ scores were compared between
short- and long-term survivors (b5 vs. ≥5 years after diagnosis)
while controlling for stage, grade, type of tumor, treatment, and
age at diagnosis. Also, the B-IPQ scores were compared between
colon and rectal cancer survivors while controlling for stage, grade,
gender, treatment, and age at diagnosis and years since diagnosis.
Finally, in order to see whether Type D personality (deﬁned by a
score ≥10 on both SI and NA) has additional value compared to
negative affectivity only (deﬁned by a score of >10 on NA), we com-
pared mean scores on the B-IPQ with ANCOVA between 1) those
with a Type D personality, 2) those with a high score (≥10) on NA
but low score on (b10) on SI, and 3) those with a low score (b10)
on NA. Again, confounding background variables included for ad-
justment in these analyses were determined a priori [30] and chosen
to be socioeconomic status, comorbidity, educational level, gender
and depressive symptoms.
Furthermore, the answers to the open-ended question of the B-IPQ
regarding the main cause of the disease (e.g. colorectal cancer) were2010 Data collection
6197 survivors £85 years at 
time of study and registered in 
the ECR with colon or rectal 
cancer,  
diagnosed between January 
(Ex)-attending specialists from 
10 hospitals were invited for 
study participation and to allow 
access to 3978 patients 
1 participating hosp ital excluded its 
rectal cancer patients due to other 
ongoin g research: 169 
Status of the remaining 3809 
survivors were checked against 
ECR and hos pital records
Double selections: 36 
Unverifiable address: 341 
Patient demented/terminally ill: 63 
Tumor not staged: 83  
622 (19%) patients either actively 
refused or did not return the 
A questionnaire was sent to the 
remaining 3286 survivors 
Survivors who had been previously 
selected for a CRC study: 2219  
2664 (81%) survivors returned a 
completed questionnaire
Respondents who completed both an 
online and paper questionnaire: 44 
and 2010  
1 
collection 
tionnaire. 
xcluded.   
n study:  
2620 (81%) completed 
questionnaires of which 1043 
(40%) were completed online
ECR1, Eindhoven Cancer Registry.
data collection process.
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compared with chi-square analyses. Finally, multivariate linear regres-
sion models were used to investigate the association between illness
perception and Type D personality. A range of sociodemographic and
clinical variables was controlled for in multivariate models.
To reduce the risk of Type II errors frommultiple testing, statistical dif-
ferences were indicated if pb0.01. Reported p-values were two-sided. All
statistical analyses were performed using SAS (version 9.2 for Windows,
SAS institute Inc., Cary NC).
Results
Demographic and clinical characteristics
Eighty-one percent (n=3977) of the 4968 cancer survivors returned a completed
questionnaire (Fig. 1). In general, respondents, non-respondents and patients with
unveriﬁable addresses differed signiﬁcantly with respect to demographic and clinical
characteristics (Table 1). Non-respondents were signiﬁcantly older and were more
often female. In addition, they were more often diagnosed with colon cancer, had dis-
ease stage II, and they were more often treated with surgery only. Finally, those with
non-veriﬁed addresses were diagnosed earlier.
In total, 750 (19%) colorectal cancer patients could be classiﬁed as having a Type D
personality (Table 2). There were no statistically signiﬁcant differences observed be-
tween colorectal cancer survivors with and without a Type D personality in age at
time of survey, years since diagnosis, type of tumor, tumor stage, grade, primary treat-
ment, body mass index, marital status, and current work (or employment) status.
However, cancer survivors with a Type D personality were more often male, reported
more comorbid conditions, more often reported depressive symptoms, had a lower ed-
ucational level, and had a lower socioeconomic status than non-Type D's.
Illness perceptions
Signiﬁcant differences were found between colorectal cancer survivors with and
without a Type D personality regarding illness perceptions, even after controlling for so-
cioeconomic status, comorbidity, educational level, gender and depressive symptoms
(Table 3a). Those with a Type D personality believe that their illness has signiﬁcantlyTable 1
Demographic and clinical characteristics of selected sample by response status.
Mean±SD or n (%)
Respondents
(n=3977)
N
(
Mean age at time of survey (± SD) 69.4±9.6 7
Mean years since last diagnosis (± SD) 4.7±2.6 4
Gender
Male 2213 (56) 4
Female 1764 (44) 4
Type of tumor
Colon 2504 (63) 6
Rectal 1473 (37) 2
Cancer stage
1 1157 (29) 2
2 1469 (37) 3
3 1106 (28) 2
4 185 (5) 3
Unknown 60 (2) 1
Cancer grade
1 308 (8) 7
2 2454 (65) 5
3 506 (13) 1
Unknown 497 (13) 1
Primary treatment
SU only 1979 (50) 5
SU+RT 856 (22) 1
SU+CT 827 (21) 1
SU+RT+CT 275 (7) 5
CT only 25 (1) 8
RT only 3 (0.1) 2
SU: surgery; RT: radiotherapy; CT: chemotherapy.
Some variables exceed 100% due to rounding off.
We used t-tests for continuous variables and chi-square analyses for categorical variables.more serious consequences (consequences), will last signiﬁcantly longer (timeline), and
experience signiﬁcantly more symptoms that they attribute to their illness (identity).
Also, they are more concerned about their illness (concern), and their disease more
often inﬂuences them emotionally (emotional response). Differences regarding ‘conse-
quences’, ‘concern’ and ‘emotional response’ were also clinically relevant according to
Norman's rule of thumb of half a standard deviation [31]. In comparison, differences be-
tween short- and long-term (b5 vs. ≥5 years) survivors were statistically signiﬁcant
(allpb0.0001) except for ‘personal control’. However, these differenceswere not clinically
relevant (data not shown) [31]. Also, differences between colon and rectal cancer survi-
vors on this questionnaire were much smaller. The only signiﬁcant differences were
found for ‘consequences’ (3.6 vs. 4.3; pb0.001), ‘timeline’ (3.6 vs. 4.4; pb0.01), and ‘iden-
tity’ (3.1 vs. 3.9; pb0.01) and these differences were not clinically relevant.
In order to see whether Type D personality (deﬁned by a score ≥10 on both SI and
NA) has additional value compared to negative affectivity (deﬁned by a score of >10 on
NA only), we comparedmean scores on the B-IPQ between1) thosewith a TypeDperson-
ality, 2) thosewith a high score (≥10) on NA but low score (b10) on SI, and 3) thosewith
a low score (b10) on NA (Table 3b). Results showed that those with a Type D personality
and those with a high score on NA reported worse signiﬁcantly scores for ‘consequences’,
‘timeline’, ‘identity’, ‘concern’, and ‘understanding’ compared to those with low scores on
NA. In addition, those with a Type D personality scored signiﬁcantly different on ‘personal
control’ compared to those with high or low scores on NA. Finally, all three subgroups had
signiﬁcantly different scores on ‘emotional response’.
Sixty-four percent of patients (n=2536) ﬁlled out the open-ended question on the
cause of their disease. The majority of patients stated that the cause of their disease was
unknown (n=591; 23.3%), hereditary (n=513; 20.3%), lifestyle (n=383; 15.1%), psy-
chological distress (n=301; 11.9%) or other (n=294; 11.6%). Differences between
those with and without a Type D personality were found for psychological distress
(16.2% vs. 10.9%; pb0.01 respectively), randomness (1.7% vs. 5.3%; pb0.01) and unknown
(18.8% vs. 24.4%; pb0.01) (Fig. 2).
In multivariate analyses, Type D personality was positively associated with the
subscale ‘consequences’, meaning that the illness of these patients (e.g. colorectal
cancer) affected their life more (Table 4). Furthermore, Type D was negatively asso-
ciated with ‘coherence’ meaning that those with a Type D personality expressed a
lower understanding of their illness. Also, Type D was positively associated with
the subscale ‘timeline’, meaning that they believe that their illness will last long.
Moreover, Type D was positively associated with ‘identity’ so they experienced
more symptoms from their illness. In addition, Type D was positively associated
with ‘concern’ which implies that Type Ds are more concerned about their illness. Fi-
nally, it was positively associated with ‘emotional representation’ which indicates
that they are more emotionally affected by their illness.on-respondents
n=933)
Non-veriﬁed addresses
(n=490)
p-Value
2.2±9.9 68.4±12.2 b0.0001
.8±2.8 5.3±2.9 0.0008
39 (47) 249 (51) b0.0001
94 (53) 241 (49)
0.0022
43 (69) 305 (62)
90 (31) 185 (38)
b0.01
40 (26) 133 (27)
93 (42) 191 (39)
49 (27) 121 (25)
4 (4) 33 (7)
7 (2) 12 (2)
0.87
3 (8) 39 (9)
86 (66) 285 (56)
18 (13) 61 (13)
15 (13) 71 (16)
b0.0001
51 (59) 272 (56)
46 (16) 78 (16)
63 (18) 86 (18)
7 (6) 41 (8)
(1) 7 (1)
(0.2) 2 (0.4)
Table 2
Sociodemographic and clinical characteristics of colorectal cancer survivors, stratiﬁed by Type D personality.
N (%)
Type D personality
N=750 (19%)
Non-Type D personality
N=3227 (81%)
p-Value
Age at time of survey (mean) 69.1 (9.7) 69.5 (9.5) 0.12
Age at time of survey 0.45
b65 years 245 (32.7) 998 (30.9)
65–75 years 289 (38.5) 1323 (41.0)
>75 years 216 (28.8) 906 (28.1)
Years since diagnosis (mean) 4.6 (2.7) 4.8 (2.8) 0.57
Years since diagnosis 0.73
1–5 years 463 (61.7) 1970 (61.1)
5–10 years 287 (38.3) 1257 (39.0)
Gender 0.02
Male 389 (51.9) 1824 (56.5)
Female 361 (48.1) 1403 (43.5)
Type of tumor 0.79
Colon 469 (62.5) 2035 (63.1)
Rectal 281 (37.5) 1192 (36.9)
Cancer stage 0.34
1 206 (27.5) 951 (29.5)
2 296 (39.5) 1173 (36.4)
3 196 (26.1) 910 (28.2)
4 38 (5.1) 147 (4.6)
Unknown 14 (1.9) 46 (1.4)
Cancer grade 0.05
1 75 (10.0) 233 (7.2)
2 458 (61.1) 1996 (61.9)
3 96 (12.8) 410 (12.7)
Unknown 121 (16.1) 588 (18.2)
Treatment+ 0.37
SU only 391 (52.3) 1588 (49.4)
SU+RT 156 (20.9) 700 (21.8)
SU+CT 140 (18.7) 687 (21.4)
SU+RT+CT 53 (7.1) 222 (6.9)
CT only 7 (1) 18 (1)
RT only 0 (0) 3 (0)
Comorbidity++ b0.0001
None 174 (23.2) 1024 (31.7)
1 199 (26.5) 879 (27.2)
2+ 377 (50.3) 1324 (41.0)
Most frequent conditions
High blood pressure 242 (32.3) 1038 (32.2) 0.96
Back pain 220 (29.3) 764 (23.7) 0.0012
Osteoarthritis 196 (26.1) 777 (24.1) 0.24
Depressive symptoms+++ 344 (47.3) 436 (14.3) b0.0001
BMI 0.09
b18.4 (underweight) 12 (1.6) 34 (1.1)
18.5 to 24.9 (normal) 268 (36.5) 1042 (33.4)
25 to 29.9 (overweight) 323 (44.0) 1524 (48.8)
>30 (obese) 131 (17.9) 521 (16.7)
Marital status 0.10
Married 548 (73.8) 2407 (76.1)
Single/Divorced 78 (10.5) 255 (8.1)
Widow/Widower 117 (15.8) 501 (15.8)
Education level++++ 0.02
Low 168 (22.9) 621 (19.7)
Medium 447 (60.9) 1887 (59.9)
High 119 (16.2) 640 (20.3)
Current occupation status 0. 61
Employed 110 (15.3) 493 (16.1)
Not employed/retired 609 (84.7) 2576 (83.9)
Socioeconomic status b0.001
Low 173 (24.1) 643 (20.8)
Medium 322 (44.9) 1257 (40.7)
High 223 (31.1) 1186 (38.4)
Some variables exceed 100% due to rounding off.
+ SU: surgery; RT: radiotherapy; CT: chemotherapy.
++ adapted Self-administered Comorbidity Questionnaire [25].
+++ HADS: We used a score of 8 as a cut-off value for depressive symptoms [28,29].
++++ Education: Low (no or primary school); Medium (lower general secondary education or vocational training); High
(pre-university education, high vocational training, university).
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Table 3a
Mean scores (± SD) on Brief Illness Perception Questionnaire.
(B-IPQ) of colorectal cancer patients, stratiﬁed by Type D personality.
B-IPQ dimensions
(min–max)
Mean (± SD) p-Value
Type D
personality
(n=750)
Non-Type D personality
(n=3227)
Consequence (0–10) 5.0 (2.6) 3.6 (2.5) b0.0001*
Timeline (0–10) 4.7 (3.2) 3.7 (3.2) 0.004
Personal Control (0–10) 4.6 (2.7) 4.8 (3.2) 0.50
Treatment Control (0–10) 6.0 (2.7) 6.4 (3.2) 0.49
Identity (0–10) 4.4 (2.7) 3.2 (2.5) b0.0001
Concern (0–10) 5.1 (2.6) 3.7 (2.5) b0.0001*
Understanding (0–10) 5.6 (2.9) 6.1 (3.3) 0.14
Emotional Response (0–10) 5.0 (2.7) 3.0 (2.3) b0.0001*
The B-IPQ was used to assess illness perceptions among colorectal cancer survivors.
Confounding background variables included for adjustment in these analyses were
determined a priori [30] and chosen to be SES, comorbidity, educational level, gender
and depressive symptoms;
* Clinically relevant difference [31].
0
5
10
15
20
25
30
Type D Non-Type D
*
* = p<0.01
* *
Fig. 2. The percentage of patients that indicated the main cause of their disease, as
assessed by B-IPQ, stratiﬁed by Type D personality (N=2536).
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This large population-based study among patients with colorectal
cancer up to 10 years after diagnosis showed that the prevalence of
Type D personality was 19% in this study. This is somewhat higher
compared to the prevalence found in a recent Taiwanese study
among 124 colorectal cancer patients (11%) [35]. However, it is
quite comparable to the prevalence found in melanoma patients
(22%) [36] and the prevalence found in a mixed sample of cancer
survivors (including endometrial, colorectal, lymphoma or multiple
myeloma; 19%) [7,19].
In addition, this study showed that those with a Type D person-
ality believe that their illness has signiﬁcantly more serious conse-
quences, will last signiﬁcantly longer, and experience signiﬁcantly
more symptoms that they attribute to their illness. Also, they are
more concerned about their illness, and their disease more often in-
ﬂuences them emotionally. Furthermore, multivariate analyses
showed that, besides socio-demographic and clinical characteristics
(e.g. time since diagnosis, stage, comorbidity, treatment, sex, and
educational level), Type D personality was negatively associated
with the subscale ‘coherence’ and positively associated with theTable 3b
Mean scores on the Brief Illness Perception Questionnaire (B-IPQ) for those with a Type D p
score (b10) on negative affectivity.
Mean (± SD)
Type D High negative affe
(n=750) (n=2456)
B-IPQ
Consequence (0–10) 5.0 (2.6) 4.7 (2.7)
Timeline (0–10) 4.7 (3.2) 4.6 (3.4)
Personal Control (0–10) 4.6 (2.7) 4.4 (2.9)
Treatment Control (0–10) 6.0 (2.7) 6.3 (3.0)
Identity (0–10) 4.4 (2.7) 4.2 (2.8)
Concern (0–10) 5.1 (2.6) 4.9 (2.8)
Understanding (0–10) 5.6 (2.9) 6.0 (3.3)
Emotional representation (0–10) 5.0 (2.7) 4.6 (2.6)
Type D was deﬁned by a score ≥10 on SI and NA; NA+was deﬁned as a score ≥10 on NA
Confounding background variables included for adjustment in these analyses were determ
pressive symptoms.
*Type D personality and NA+are signiﬁcantly different from the NA-.
**Type D personality is signiﬁcantly different from NA+and NA−.
***All subgroups are signiﬁcantly different.subscales ‘consequences’ ‘timeline’, ‘identity’, ‘concern’ and ‘emo-
tional representation’. Our results are in accordance with another
study describing illness perceptions among post myocardial infarc-
tion patients with a Type D personality [17]. That study also showed
that Type Ds have a distinct and more negative proﬁle of illness be-
liefs compared to non-Type Ds. Also, a 1-year prospective study
among non-metastatic colorectal cancer patients showed that per-
sonality variables can predict psychological distress symptoms' in-
crease and HRQOL decrease over time [45].
A possible explanation for these worse illness perceptions is that
individuals with neurotic personality traits, such as those with a
Type D personality, might be more prone to somatic awareness and
monitoring for fear of disease recurrence [32]. Another explanation
might be the fact that there also is a difference in the perceived re-
ceipt of information between these two groups. A recent study
showed that cancer survivors with a Type D personality perceive to
have received less information from their doctor, and are less satisﬁed
with (the usefulness of) the received information compared to those
without a Type D personality [33]. Worse illness perceptions could
possibly also explain why cancer survivors with a Type D personality
reported more health care utilization in comparison with non-Type
Ds in a recently published study [7].ersonality, those with a high score (≥10) on negative affectivity, and those with a low
p-Value
ctivity (NA+) Low negative affectivity (NA-)
(n=463)
3.4 (2.3) b0.0001*
3.5 (3.1) b0.0001*
4.9 (3.2) 0.0009**
6.5 (3.3) b0.05*
3.0 (2.3) b0.0001*
3.4 (2.4) b0.0001*
6.2 (3.3) b0.01*
2.7 (2.1) b0.0001***
and b10 on SI; and NA- was deﬁned as a score b10 on NA, irrespective of SI.
ined a priori [30] and chosen to be SES, comorbidity, educational level, gender and de-
Table 4
Standardized betas of multivariate linear regression analyses evaluating the association of independent variables with the BIPQ scales.
B-IPQ 1
consequences
B-IPQ2
timeline
B-IPQ3 personal
control
B-IPQ4 treatment
control
B-IPQ5
identity
B-IPQ6
concern
B-IPQ7
coherence
B-IPQ8 emotional
representation
Tumor type −0.07 −0.07* 0.001 0.03 −0.07 −0.04 −0.02 −0.05
Time (since diagnosis) −0.13* −0.08* 0.04 −0.08* −0.07* −0.12* −0.07* −0.07*
Stage −0.09* −0.10* 0.03 0.04 −0.07* −0.07* −0.02 −0.06*
Comorbidity −0.08* −0.06* −0.02 −0.007 −0.09* −0.08* −0.02 −0.08*
SU+RT 0.08* 0.08* 0.04 0.03 0.12* 0.03 −0.009 0.05
SU+CT 0.05 0.003 0.02 0.07* 0.06 0.07* 0.008 0.05
SU+RT+CT 0.08* 0.003 0.03 0.08* 0.10* 0.04 0.02 0.07*
Sex −0.05* −0.05* −0.002 −0.07* −0.08* −0.7* −0.03 −0.07*
Marital status −0.04 −0.03 0.01 −0.004 −0.07* −0.03 0.03 −0.02
Educational level −0.008 −0.03 −0.02 −0.11* 0.006 0.03 −0.13* 0.04*
Socio-economic status −0.02 0.02 −0.02 0.01 0.006 0.001 −0.003 −0.009
Personality 0.20* 0.12* −0.02 −0.04 0.18* 0.20* −0.06* 0.30*
Tumor type=Colon (reference) vs. rectum; Time=>5 years after diagnosis (reference); Stage=1,2 (reference) vs. 3,4; Comorbidity=No comorbidity (reference) vs. one
or more comorbidities; SU+RT=surgery+radiotherapy (reference) vs. surgery; SU+CT=surgery+chemotherapy (reference) vs. surgery; SU+RT+CT=
surgery+radiotherapy+chemotherapy (reference) vs. surgery; Sex=Male (reference) vs. female; Marital status=Partner (reference) vs. no partner; Educational
status=High (reference) vs. low; Socio-economic status=High (reference) vs. medium or low; Personality=Type D (reference) vs. no Type D;
*p-Value of b0.01.
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causal attributions were unknown (23%), hereditary (20%), lifestyle
(15%). A recent study on causal attributions among cancer survivors
of the ten most common cancers showed quite similar results with
the three most common causal attributions being lifestyle (39%), bio-
logical (including hereditary; 35%), and environmental (24%)[34]. In
the present study, colorectal cancer survivors with a Type D personal-
ity more often indicated that the cause of their disease was psycho-
logical distress, but less likely to attribute their disease to a random
or unknown cause. Since this is the ﬁrst study on illness perceptions
and Type D personality among cancer patients, comparison of these
results with other studies is not possible.
Fromour results, payingmore attention to bothpersonality and illness
perceptions of patients seems warranted. A meta-analysis of research on
illness perceptions showed that illness perceptions predicted outcomes in
various categories of chronic physical disorders [37]. Also, previous stud-
ies showed that illness perceptions can inﬂuence the process of adjust-
ment and coping in a wide range of disease states [32,38,39]. Although
adjusting personality is difﬁcult, changing illness perceptions is possible,
however. Two brief in-hospital intervention studies changed the percep-
tions of myocardial infarction patients and this resulted in a quicker re-
turn to work in the intervention group [40,41].
The present study has some limitations that should be mentioned.
Although we had information on the demographic and clinical charac-
teristics of non-respondents and patientswith non-veriﬁable addresses,
it remains unknown whether non-respondents declined to participate
in the study because of poor health. In addition, although Type D per-
sonality is a stable construct [5,42], our cross-sectional analyses limits
the determination of causal association between Type D personality
and illness perceptions, as baseline data on these outcomes are un-
known. Future studies that address this issue would be helpful in ex-
ploring this association between Type D personality and illness
perceptions in cancer patients. Finally, we used the HADS in order to
control for depressive symptomswhen using the Type D questionnaire.
However, the HADS is not the best instrument to do this, since recent
publications have highlighted inherent drawbacks of this questionnaire
[43,44].
Despite these limitations, the present study provides an important
contribution to the limited data available on the importance of individ-
ual differences such as Type D personality regarding the illness percep-
tions of colorectal cancer survivors. Since our results are based on two
large population-based studies with a high response rate, extrapolating
these results to the larger population of colorectal cancer survivors
seems justiﬁed. These results call for further research on Type D person-
ality among various cancer survivors followed over a longer period of
time. In addition, potential underlying mechanisms that may explainthese Type-D related disparities in illness perceptions should also be in-
vestigated among cancer survivors. Furthermore, our study contributes
to the area of strengthening theoretical models about illness percep-
tions and the importance of personality characteristics in such models.
In conclusion, this study showed that patients with a Type D per-
sonality hadmore negative perceptions about their illness, were more
concerned about their illness, and felt that their disease more often
inﬂuenced them emotionally, even after adjustment for the major
clinical predictors. Also, they had different beliefs about the cause of
the disease compared to those without a Type D personality. Future
studies should investigate whether intervention studies can improve
the illness perceptions of cancer patients with a Type D personality,
and what effects these improvement have on outcomes such as qual-
ity of life, use of health care facilities, or other outcomes.
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